Skip to main content
Premium Trial:

Request an Annual Quote

SGX Grants Lilly Access to Its Beamline

NEW YORK, Jan. 15 (GenomeWeb News) - Structural Genomix said today it will provide Eli Lilly with long-term access to the SGX synchrotron beamline facility at the Advanced Photon Source at Argonne National Laboratory in Chicago.


SGX, of San Diego, Calif., will generate x-ray crystallography data on drug targets and compounds provided by Lilly. In return, Lilly will pay SGX an upfront access fee and an annual fee to cover operating costs. Lilly also has the option to expand its access to the beamline in the future for additional payments.


SGX has been providing Lilly with its high-throughput protein crystallography technology since last April.



The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.